Save the Date
La Coruña, Spain
Course Directors
Dr. Pablo Parente · Dr. Ricard Simó
About the course
This two-day course brings together leading international experts to discuss the latest evidence, controversies and clinical practice updates in the management of thyroid cancer — from differentiated and medullary to anaplastic disease.
Surgical decision-making, RAI, dynamic risk stratification, robotic approaches and de-escalation strategies.
PORT, targeted kinase inhibitors and multidisciplinary management of advanced disease.
Genetics, MEN syndromes, surgical management of primary and recurrent disease, and new systemic therapies.
Real-world cases debated by a multidisciplinary expert panel across both days.
Scientific Programme
| 09:00–10:00 | Registration, Welcome and Introduction |
| Morning Sessions | |
| 10:00–10:30 | Cytological and Histological Classification of Thyroid Nodules and Tumours |
| 10:30–11:00 | Evaluation of Thyroid Nodules: Integrating Imaging (EU-TIRADS), Cytology and Molecular Markers |
| 11:00–11:30 | Coffee Break |
| 11:30–12:00 | Low-risk Thyroid Cancer: Active Surveillance vs Minimally Invasive Treatment vs Surgery |
| 12:00–12:30 | Surgical De-escalation: Lobectomy vs Total Thyroidectomy in DTC |
| 12:30–13:00 | Prophylactic Neck Dissection in Differentiated Thyroid Cancer: Is There a Role? |
| 13:00–14:00 | Clinical Case Discussions Expert Panel |
| 14:00–15:00 | Lunch |
| Afternoon Sessions | |
| 15:00–15:30 | Definition and Surgical Management of Locally Advanced Thyroid Carcinoma |
| 15:30–16:00 | Minimally Invasive and Remote Access Thyroid Surgery (MIVAT, TOETVA, Transaxillary, Retroauricular) |
| 16:00–16:30 | Coffee Break |
| 16:30–17:00 | New Technologies in Thyroid Surgery: cIONM, NIRAF Fluorescence, VR |
| 17:00–17:30 | Prevention and Management of Complications in Thyroid Cancer Surgery |
| 17:30–18:00 | Persistent or Recurrent Thyroid Cancer: Management |
| 18:00 | End of Day One |
| 09:00–10:00 | Registration, Welcome and Introduction |
| Morning Sessions | |
| 10:00–10:30 | The Genetic Landscape of Thyroid Cancer and its Clinical Implications |
| 10:30–11:00 | Medullary Thyroid Cancer: Diagnosis, Genetics and Surgical Strategy |
| 11:00–11:30 | Coffee Break |
| 11:30–12:00 | Calcitonin-guided Neck Dissection in MTC: 20/50/200/500 pg/mL Thresholds |
| 12:00–12:30 | Long-term Follow-up after Initial Therapy: Which Tests? How Often? How Long? |
| 12:30–13:00 | Systemic Therapy for Metastatic and Advanced Thyroid Cancer |
| 13:00–14:00 | Clinical Case Discussions Expert Panel |
| 14:00–15:00 | Lunch |
| Afternoon Sessions | |
| 15:00–15:30 | Postoperative Hypoparathyroidism: Prevention and New Management Guidelines |
| 15:30–16:00 | Adjuvant Treatment with Immunotherapy in Differentiated Thyroid Cancer |
| 16:00–16:30 | Coffee Break |
| 16:30–17:00 | Anaplastic Thyroid Cancer: Multidisciplinary and Targeted Approaches |
| 17:00–17:30 | Multidisciplinary Tumour Board: Integrating Surgery, Endocrinology and Oncology |
| 17:30–18:00 | Discussion, Take-home Messages and Closure Dr. Pablo Parente & Dr. Ricard Simó |
| 18:00 | End of Day Two |
Venue
Full address and directions will be published as the event approaches.
Discover A Coruña